Novozymes A/S (NSIS-B.CO)
DKK 409.4
(-0.8%)
DKK 409.4
(-0.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.04 Billion DKK | 2.07% |
| 2022 | 13.75 Billion DKK | 9.51% |
| 2021 | 12.56 Billion DKK | 35.56% |
| 2020 | 9.26 Billion DKK | 3.45% |
| 2019 | 8.95 Billion DKK | 8.45% |
| 2018 | 8.25 Billion DKK | 16.23% |
| 2017 | 7.1 Billion DKK | 2.78% |
| 2016 | 6.91 Billion DKK | 11.55% |
| 2015 | 6.19 Billion DKK | -13.27% |
| 2014 | 7.14 Billion DKK | 31.36% |
| 2013 | 5.44 Billion DKK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 31.68 Billion DKK | 125.65% |
| 2024 Q2 | 31.68 Billion DKK | -0.01% |
| 2023 Q1 | 14.99 Billion DKK | 9.04% |
| 2023 FY | 14.04 Billion DKK | 2.07% |
| 2023 Q4 | 14.04 Billion DKK | 2.87% |
| 2023 Q3 | 13.64 Billion DKK | -5.41% |
| 2023 Q2 | 14.42 Billion DKK | -3.79% |
| 2022 Q4 | 13.75 Billion DKK | -1.27% |
| 2022 Q3 | 13.93 Billion DKK | -0.5% |
| 2022 FY | 13.75 Billion DKK | 9.51% |
| 2022 Q2 | 14 Billion DKK | 3.0% |
| 2022 Q1 | 13.59 Billion DKK | 8.22% |
| 2021 FY | 12.56 Billion DKK | 35.56% |
| 2021 Q4 | 12.56 Billion DKK | 22.57% |
| 2021 Q3 | 10.24 Billion DKK | -4.25% |
| 2021 Q2 | 10.7 Billion DKK | -1.83% |
| 2021 Q1 | 10.9 Billion DKK | 17.66% |
| 2020 Q4 | 9.26 Billion DKK | -0.54% |
| 2020 Q1 | 9.65 Billion DKK | 7.84% |
| 2020 Q2 | 9.89 Billion DKK | 2.42% |
| 2020 Q3 | 9.31 Billion DKK | -5.83% |
| 2020 FY | 9.26 Billion DKK | 3.45% |
| 2019 Q3 | 8.94 Billion DKK | -0.98% |
| 2019 Q1 | 9.46 Billion DKK | 14.58% |
| 2019 FY | 8.95 Billion DKK | 8.45% |
| 2019 Q2 | 9.03 Billion DKK | -4.5% |
| 2019 Q4 | 8.95 Billion DKK | 0.1% |
| 2018 FY | 8.25 Billion DKK | 16.23% |
| 2018 Q2 | 8.13 Billion DKK | -1.94% |
| 2018 Q3 | 8.03 Billion DKK | -1.22% |
| 2018 Q1 | 8.29 Billion DKK | 16.79% |
| 2018 Q4 | 8.25 Billion DKK | 2.74% |
| 2017 Q4 | 7.1 Billion DKK | -2.94% |
| 2017 Q2 | 7.38 Billion DKK | -6.66% |
| 2017 Q1 | 7.91 Billion DKK | 14.42% |
| 2017 FY | 7.1 Billion DKK | 2.78% |
| 2017 Q3 | 7.32 Billion DKK | -0.85% |
| 2016 Q1 | 6.89 Billion DKK | 11.26% |
| 2016 FY | 6.91 Billion DKK | 11.55% |
| 2016 Q4 | 6.91 Billion DKK | 1.05% |
| 2016 Q3 | 6.84 Billion DKK | 0.71% |
| 2016 Q2 | 6.79 Billion DKK | -1.48% |
| 2015 Q3 | 6.81 Billion DKK | -4.36% |
| 2015 Q1 | 7.2 Billion DKK | 0.8% |
| 2015 Q2 | 7.13 Billion DKK | -1.01% |
| 2015 FY | 6.19 Billion DKK | -13.27% |
| 2015 Q4 | 6.19 Billion DKK | -9.11% |
| 2014 FY | 7.14 Billion DKK | 31.36% |
| 2014 Q1 | 7.03 Billion DKK | 29.25% |
| 2014 Q2 | 7.38 Billion DKK | 4.96% |
| 2014 Q3 | 7.79 Billion DKK | 5.56% |
| 2014 Q4 | 7.14 Billion DKK | -8.27% |
| 2013 Q1 | 6.51 Billion DKK | 0.0% |
| 2013 FY | 5.44 Billion DKK | 0.0% |
| 2013 Q2 | 6.04 Billion DKK | -7.23% |
| 2013 Q3 | 5.33 Billion DKK | -11.72% |
| 2013 Q4 | 5.44 Billion DKK | 1.99% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Flügger group A/S | 1.11 Billion DKK | -1155.772% |
| Hove A/S | 24.99 Million DKK | -56076.66% |
| SP Group A/S | 1.55 Billion DKK | -802.277% |